Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan-Reference-Cited by-同舟云学术

Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan

Published:2018-01-18 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Bilsland Elizabeth,van Vliet Liisa,Williams Kevin,Feltham Jack,Carrasco Marta P.,Fotoran Wesley L.,Cubillos Eliana F. G.,Wunderlich Gerhard^ORCID,Grøtli Morten,Hollfelder Florian^ORCID,Jackson Victoria,King Ross D.^ORCID,Oliver Stephen G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-19549-x.pdf

Reference42 articles.

1. Wells, T. N., van Huijsduijnen, R. H. & Van Voorhis, W. C. Malaria medicines: a glass half full? Nature reviews. Drug discovery 14, 424–442 (2015).

2. Melo, G. C. et al. Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon. PLoS One 9, e105922 (2014).

3. Mikolajczak, S. A. et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 17, 526–535 (2015).

4. Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nature genetics 47, 226–234 (2015).

5. Fairhurst, R.M. Understanding artemisinin-resistant malaria: what a difference a year makes. Current opinion in infectious diseases (2015).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The characteristic structural and functional dynamics of P. falciparum DHFR binding with pyrimidine chemotypes implicate malaria therapy design;Chemical Physics Impact;2024-12

2. To quest new targets of Plasmodium parasite and their potential inhibitors to combat antimalarial drug resistance;Journal of Parasitic Diseases;2024-05-31

3. Ex -identification and scientific discovery;International Journal of Parallel, Emergent and Distributed Systems;2024-05-07

4. Target-Based 6-5 Fused Ring Heterocyclic Scaffolds Display Broad Antiparasitic Potency In Vitro;Future Pharmacology;2024-02-28

5. Artificial Intelligence for Drug Discovery: Are We There Yet?;Annual Review of Pharmacology and Toxicology;2024-01-23